Pharmacyclics Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative small-molecule drugs for read more

EMPLOYEE PARTICIPANTS: 8

TOTAL RATINGS: 127

CEO

Pharmacyclics CEO Rating

Pharmacyclics' CEO has 7 employee ratings and a score of 54/100, placing them in the Bottom 10% of similar size companies on Comparably with 501-1,000 Employees and Bottom 10% of other companies in San Francisco.

Last updated a month ago.

Where This Score Ranks Pharmacyclics' CEO Rating

BOTTOM
10%
In the Bottom 10% of 1832 Similar Sized Companies on Comparably
BOTTOM
10%
In the Bottom 10% of 931 Nearby Companies in San Francisco
5th
5th place versus 4 competitors rated on Comparably

Aug

Jun

May

Nov

Mar

D-54 / 100

Sep

Who Ranks Pharmacyclics' CEO Rating the Highest?

Ethnicity - African American/Black 53/100

Tenure - Less than 1 Year 47/100

Gender - Male 43/100

Who Ranks Pharmacyclics' CEO Rating the Lowest?

Not Enough Ratings To Show Who Ranks CEO Rating the Lowest

Anonymously rate my experience at Pharmacyclics

Pharmacyclics CEO Rating At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Pharmacyclics.

Based on 7 ratings, Pharmacyclics' CEO ranks right below Incyte's CEO, Hervé Hoppenot.

Pharmacyclics' CEO is highly regarded by African American/Black employees, employees who have been at the company Less than 1 Year, and Male employees. Overall, the CEO score has remained stable over the last 90 days.